News

Deal Announcements

MacroGenics Closes $25 Million Venture Capital Round

Friday, September 26, 2008 5:34:00 AM PDT | Venturedeal Staff
Rockville, Maryland  --  Biotechnology company MacroGenics announced that it has raised $25 million in a new round of venture capital financing from a syndicate of firms.

Macrogenics is focused on developing immunotherapeutics for autoimmune disorders, infectious diseases and cancer.

Investors in the round included Innovis Investments, Alexandria Real Estate Equities, Alta Partners, InterWest Partners, OrbiMed, Red Abbey Venture Partners, Rivervest Venture Partners and Ventures West.

The company said it would use the proceeds from the financing to fund its cancer stem cell program and further advance its other candidate portfolio.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1